Cargando…
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial
BACKGROUND: Patients with high Gleason score, elevated prostate specific antigen (PSA) level, and advanced clinical stage are at increased risk for both local and systemic relapse. Recent data suggests higher radiation doses decrease local recurrence and may ultimately benefit biochemical, metastasi...
Autores principales: | Konaka, Hiroyuki, Egawa, Shin, Saito, Shiro, Yorozu, Atsunori, Takahashi, Hiroyuki, Miyakoda, Keiko, Fukushima, Masanori, Dokiya, Takushi, Yamanaka, Hidetoshi, Stone, Nelson N, Namiki, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350387/ https://www.ncbi.nlm.nih.gov/pubmed/22439742 http://dx.doi.org/10.1186/1471-2407-12-110 |
Ejemplares similares
-
Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial
por: Miki, Kenta, et al.
Publicado: (2010) -
Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study
por: Nakano, Masahiro, et al.
Publicado: (2015) -
Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey
por: Kojima, Toru, et al.
Publicado: (2023) -
Prospective longitudinal comparative study of health-related quality of life and treatment satisfaction in patients treated with hormone therapy, radical retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer
por: Miwa, Sotaro, et al.
Publicado: (2013) -
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
por: Ohashi, Toshio, et al.
Publicado: (2014)